Pharma Archives - Feedback

Pharma

Health-tech platform Medlife is planning to expand its presence in the retail pharmacy segment by opening around 750 pharmacies across the country in two years. The company, which is a leading player in the online pharmacy segment, is mainly looking at acquisitions to achieve the target. https://www.business-standard.com/article/companies/medlife-plans-to-open-750-retail-pharmacies-across-india-by-2020-end-119011300096_1.html

US-drug maker Pfizer will be shutting down two of its facilities in Aurangabad, Maharashtra and Irungattukottai (IKKT) near Chennai in Tamil Nadu citing non-viability of operations. The closures will affect 1700 employed at both locations of the company which has a total of five manufacturing sites across the country. https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/pfizer-to-stop-manufacturing-in-its-chennai-and-aurangabad-facilities/articleshow/67456313.cms

Drug major Sun Pharma has completed acquisition of Japan-based Pola Pharma to strengthen its presence in dermatology segment across the globe. The acquisition of 100 % shares of Pola Pharma Inc Japan by the company’s wholly owned subsidiary has been concluded. https://www.business-standard.com/article/companies/sun-pharma-acquires-japan-s-pola-pharma-to-expand-in-dermatology-segment-119010300702_1.html

Bristol-Myers Squibb Co would buy Celgene Corp for about $74 billion, combining two of the world’s largest cancer drug businesses in the biggest pharmaceutical deal ever. Both Bristol-Myers and Celgene face separate challenges, and some Wall Street analysts questioned whether the combination – which the companies said would create $2.5 billion in cost savings and […]

The foundation stone of a 136-bed hospital building in the premises of Coronation Hospital at Curzon Road. Rawat also announced a CT scan, X-ray, blood bank and an emergency ward with 16 beds for the hospital. The hospital is set to open to public on June 23, 2020. It will be built in an area […]

Healthcare sector may see further consolidation in 2019 with tightening of regulatory environment set to make it difficult for small players to stay afloat in a highly competitive market. Industry players also expect more partnerships in the new year between public and private sector in the healthcare space, which they feel is ‘under-invested’. Already, Malaysia’s […]

Hyderabad-headquartered Aurobindo Pharmaceuticals, which draws around 47 per cent of its revenues from the US, is a late entrant in the biosimilars and injectables space. In the second quarter, AuroMedics, the company’s injectable business, witnessed an 8 per cent year-on-year growth to $50 million. The company has already filed a total of 104 injectables, abbreviated […]

MMTC Ltd, the state owned trading entity, aims to commence exports of engineering goods and pharmaceutical products from Q1 of next fiscal. The company is looking at transactions in new commodities and go beyond its forte in trade of bullion and major bulk minerals like iron ore and chromite. MMTC is awaiting award of drug […]

KKR-led Radiant Life Care is in advanced talks to acquire Max Healthcare, Max India’s hospital chain. Under the deal that’s expected to be announced next week, Max India will first be split to create a pureplay listed holding company. Max Healthcare will then merge with Radiant Life Care. This combined entity will then be merged […]

Drug firm Aurobindo Pharma arm Helix Healthcare BV has entered into a pact with Shandong Luoxin Pharmaceutical Group Stock Co to establish a JV firm in China to manufacture nebuliser inhaler and other products for China, the US and the EU. The percentage of shareholding in the joint venture company will be 30 per cent […]